Published Paper Details:

Aerosols are formulations comprising finely dispersed particles or droplets suspended in a gas, widely utilized in pharmaceutics for their efficiency in drug delivery. These systems are integral in the administration of medications via inhalers, nebulizers, and metered-dose inhalers (MDIs), offering a significant advantage in targeting pulmonary tissues, thereby enhancing drug bioavailability and therapeutic efficacy. include rapid onset of action, minimized systemic side effects, and the convenience of self-administration. Aerosols facilitate precise dosage control and can deliver medications directly to the site of action, improving therapeutic outcomes and patient compliance. However, there are notablesuch as issues with stability and formulation complexity. The propellants used, traditionally chlorofluorocarbons (CFCs), have raised environmental concerns, leading to the development of environmentally friendly alternatives like hydrofluoroalkanes (HFAs). of aerosols in the future are promising, with ongoing advancements in nanotechnology and biomaterials enhancing their efficiency and targeting capabilities. Innovations in inhaler design and formulation science are expected to improve drug delivery systems, potentially expanding their use beyond respiratory disorders to include systemic and localized treatments.In conclusion, aerosols represent a dynamic and evolving domain in pharmaceutics, poised to revolutionize drug delivery and patient care with continued research and technological advancements